The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Voluhemin A ID: ALA5283833
Max Phase: Preclinical
Molecular Formula: C37H51NO8
Molecular Weight: 637.81
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)=C[C@H]1O[C@H]2[C@H]3O[C@@]34[C@H](CC[C@@]3(C)[C@@]4(O)CC[C@H]4C[C@@]5(O)c6c(CC7OC7(C)C)cccc6N[C@@]5(O)[C@@]43C)O[C@@H]2C(C)(C)O1
Standard InChI: InChI=1S/C37H51NO8/c1-19(2)16-25-43-27-28(31(5,6)45-25)42-23-13-14-32(7)33(8)21(12-15-35(32,40)36(23)29(27)46-36)18-34(39)26-20(17-24-30(3,4)44-24)10-9-11-22(26)38-37(33,34)41/h9-11,16,21,23-25,27-29,38-41H,12-15,17-18H2,1-8H3/t21-,23-,24?,25-,27+,28-,29+,32+,33-,34+,35-,36-,37+/m0/s1
Standard InChI Key: PYSWWYGVLWQSNR-QWIUXTLFSA-N
Molfile:
RDKit 2D
51 59 0 0 0 0 0 0 0 0999 V2000
2.0985 -0.7949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0985 -1.6198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5275 -0.7949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6696 -1.6198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6696 -0.7949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3841 -0.3824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0448 -0.3824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7593 -0.7949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0448 -2.0324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4737 -0.3822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4737 0.4426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7432 0.0302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2582 -0.6372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8130 -2.0325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5275 -1.6198 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.8130 -0.3824 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.2422 -0.3822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2422 0.4428 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9568 0.8554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5275 0.8554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3996 -2.7484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2248 -2.7484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3841 -2.0324 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.6696 0.0285 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.3841 0.4427 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.7593 -1.6198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7592 0.8551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0448 0.4426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2582 0.6976 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7434 -1.3046 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.5278 -1.0495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5278 -0.2246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2453 0.1895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9568 -0.2268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9568 -1.0476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2405 -1.4600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2453 1.0148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5306 1.4274 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7038 1.4274 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.1172 2.1416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7038 2.8576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5290 2.8576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8457 -1.3519 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.2282 0.6979 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.4737 1.2678 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.2601 -1.1795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7593 0.0303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0448 -1.2076 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.6696 -2.4452 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
2.8132 -1.2073 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
2.0985 0.0302 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
5 4 1 0
6 5 1 0
1 6 1 0
5 7 1 0
7 8 1 0
4 9 1 0
8 10 1 0
11 10 1 0
13 12 1 0
10 13 1 0
2 14 1 0
15 3 1 0
14 15 1 0
3 16 1 0
1 16 1 0
3 17 1 6
17 18 2 0
18 19 1 0
18 20 1 0
14 21 1 0
14 22 1 0
4 23 1 0
2 23 1 0
5 24 1 6
6 24 1 0
6 25 1 1
26 9 1 0
8 26 1 0
27 11 1 0
28 27 1 0
7 28 1 0
12 29 1 0
11 29 1 0
13 30 1 0
30 31 1 0
31 32 2 0
12 32 1 0
32 33 1 0
33 34 2 0
34 35 1 0
35 36 2 0
31 36 1 0
33 37 1 0
37 38 1 0
39 38 1 0
39 40 1 0
38 40 1 0
40 41 1 0
40 42 1 0
13 43 1 1
12 44 1 1
11 45 1 1
10 46 1 6
8 47 1 1
7 48 1 6
4 49 1 6
2 50 1 6
1 51 1 1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 637.81Molecular Weight (Monoisotopic): 637.3615AlogP: 4.45#Rotatable Bonds: 3Polar Surface Area: 125.47Molecular Species: NEUTRALHBA: 9HBD: 4#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski): 1CX Acidic pKa: 10.97CX Basic pKa: ┄CX LogP: 4.57CX LogD: 4.57Aromatic Rings: 1Heavy Atoms: 46QED Weighted: 0.28Np Likeness Score: 1.77
References 1. Bhattacharjee P, Rutland N, Iyer MR.. (2022) Targeting Sterol O -Acyltransferase/Acyl-CoA:Cholesterol Acyltransferase (ACAT): A Perspective on Small-Molecule Inhibitors and Their Therapeutic Potential., 65 (24.0): [PMID:36473091 ] [10.1021/acs.jmedchem.2c01265 ] 2. Pokhrel, Laxman and 5 more authors. 2012-10-25 Inhibition of Acyl-CoA: cholesterol acyltransferase (ACAT), overexpression of cholesterol transporter gene, and protection of amyloid β (Aβ) oligomers-induced neuronal cell death by tricyclic pyrone molecules. [PMID:23025824 ] 3. Ting, Pauline C PC and 10 more authors. 2013-02-15 Lead optimization of a pyridine-carboxamide series as DGAT-1 inhibitors. [PMID:23317570 ] 4. Eguchi, Keisuke K and 10 more authors. 2013-07-01 Manzamine A, a marine-derived alkaloid, inhibits accumulation of cholesterol ester in macrophages and suppresses hyperlipidemia and atherosclerosis in vivo. [PMID:23665143 ]